Cellular senescence and failure of myelin repair in multiple sclerosis
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Remyelination is a physiological response to demyelinating events aiming to restore saltatory conduction and preserve axonal integrity. Resident oligodendrocyte precursor cells (OPC) of the CNS tissue under appropriate conditions are mobilized to proliferate, migrate, and differentiate, in order to produce new myelin sheaths in the demyelinated lesion. In multiple sclerosis (MS), the most common immune-mediated demyelinating disease, remyelination efficiency declines with increasing age and disease duration. As myelin regeneration attempts in clinical trials so far are scarce, and have been met with limited success, the need to explore new remyelinating strategies is more compelling. Recently, ageing and cellular senescence have been implicated in the pathophysiology of a number of neurodegenerative diseases, including multiple sclerosis. Evidence on OPC senescence brings forward the possibility of exploiting cellular senescence as a possible target for promoting the endogenous remyelinating capacity of the CNS. Here we discuss the data indicating how cellular senescence affects remyelination, and the putative benefits to be drawn through the use of senolytic or senomorphic therapies targeting senescent cell populations in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Models of accelerated cellular senescence show premature ageing and indicate that cellular senescence may contribute to neurodegeneration associated with ageing and age-related conditions (Baker et al., 2011; Kevin Howcroft et al., 2013; Kritsilis et al., 2018).”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Self-citationFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 2×
“Most of these triggers lead to DNA damage and typically activate the complex signal transduction system of DNA damage response (DDR), which may elicit CS (Nakamura et al., 2008; Rodier and Campisi, 2011; Turenne et al., 2001).”
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Self-citationOcrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606468 · Cited by 1,905
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523
Autophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355 · cited 1×
“Ageing has been shown to affect the capacity for myelin repair in several animal models of demyelination (Cantuti-Castelvetri et al., 2018; Gilson and Blakemore, 1993; Hampton et al., 2012; Shen et al., 2008; Shields et al., 1999).”
Background
Research works printed but not linked: 131
- Alizadeh, 2015, Myelin damage and repair in pathologic CNS: challenges and prospects, Front. Mol. Neurosci., 8, 1, 10.3389/fnmol.2015.00035 · DOI · Paper page
- Baranzini, 2000, Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression, J. Immunol., 165, 6576, 10.4049/jimmunol.165.11.6576 · DOI · Paper page
- Barbouti, 2019, In situ evidence of cellular senescence in Thymic Epithelial Cells (TECs) during human thymic involution, Mech. Ageing Dev., 177, 88, 10.1016/j.mad.2018.02.005 · DOI · Paper page
- Baron, 2000, Perturbation of myelination by activation of distinct signaling pathways: an in vitro study in a myelinating culture derived from fetal rat brain, J. Neurosci. Res., 59, 74, 10.1002/(SICI)1097-4547(20000101)59:1<74::AID-JNR9>3.0.CO;2-P · DOI
- Bevan, 2018, Meningeal inflammation and cortical demyelination in acute multiple sclerosis, Ann. Neurol., 84, 829, 10.1002/ana.25365 · DOI · Paper page
- Bin, 2013, Full-length and fragmented netrin-1 in multiple sclerosis plaques are inhibitors of oligodendrocyte precursor cell migration, Am. J. Pathol., 183, 673, 10.1016/j.ajpath.2013.06.004 · DOI
- Black, 2006, Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Na v1.6 and K v1.2 at nodes of Ranvier, Brain, 129, 1319, 10.1093/brain/awl057 · DOI
- Bodini, 2016, Dynamic imaging of individual remyelination profiles in multiple sclerosis, Ann. Neurol., 79, 726, 10.1002/ana.24620 · DOI · Paper page
- Boyd, 2013, Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models, Acta Neuropathol., 125, 841, 10.1007/s00401-013-1112-y · DOI · Paper page
- Bramow, 2010, Demyelination versus remyelination in progressive multiple sclerosis, Brain, 133, 2983, 10.1093/brain/awq250 · DOI · Paper page
- Brown, 2014, Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis, Neuroimage Clin., 6, 20, 10.1016/j.nicl.2014.06.009 · DOI · Paper page
- Burbidge, 2002, Molecular cloning, distribution and functional analysis of the NAV1.6. Voltage-gated sodium channel from human brain, Mol. Brain Res., 103, 80, 10.1016/S0169-328X(02)00188-2 · DOI
- Butt, 2005, Opposing actions of fibroblast growth factor-2 on early and late oligodendrocyte lineage cells in vivo, J. Neuroimmunol., 166, 75, 10.1016/j.jneuroim.2005.05.015 · DOI
- Cadavid, 2017, Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial, Lancet Neurol., 16, 189, 10.1016/S1474-4422(16)30377-5 · DOI · Paper page
- Cadavid, 2019, Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial, Lancet Neurol., 18, 845, 10.1016/S1474-4422(19)30137-1 · DOI · Paper page
- Chamberlain, 2016, Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis, Neuropharmacology, 10.1016/j.neuropharm.2015.10.010 · DOI · Paper page
- Chang, 2000, NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions, J. Neurosci., 10.1523/JNEUROSCI.20-17-06404.2000 · DOI · Paper page
- Charles, 2002, Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?, Brain, 125, 1972, 10.1093/brain/awf216 · DOI · Paper page
- Coman, 2006, Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis, Brain, 129, 3186, 10.1093/brain/awl144 · DOI · Paper page
- Coppé, 2010, The senescence-associated secretory phenotype: the dark side of tumor suppression, Annu. Rev. Pathol. Mech. Dis., 5, 99, 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
- Craner, 2004, Co- localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE, Brain, 127, 294, 10.1093/brain/awh032 · DOI · Paper page
- Crawford, 2016, Pre-existing mature oligodendrocytes do not contribute to remyelination following toxin-induced spinal cord demyelination, Am. J. Pathol., 186, 511, 10.1016/j.ajpath.2015.11.005 · DOI · Paper page
- Cunniffe, 2019, Promoting remyelination in multiple sclerosis, J. Neurol.
- Dawson, 2000, NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors?, J. Neurosci. Res., 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.0.CO;2-N · DOI · Paper page
- De Angelis, 2018, Disease-modifying therapies for multiple sclerosis, BMJ, 4674, 1
- de Barcelos, 2019, Mitochondrial dysfunction and multiple sclerosis, Biology (Basel), 8
- de Jong, 2018, Galectin-4, a negative regulator of oligodendrocyte differentiation, is persistently present in axons and microglia/ macrophages in multiple sclerosis lesions, J. Neuropathol. Exp. Neurol., 77, 1024, 10.1093/jnen/nly081 · DOI
- Debacq-Chainiaux, 2005, Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-β1 signaling pathway, J. Cell. Sci., 118, 743, 10.1242/jcs.01651 · DOI · Paper page
- Dusart, 1992, Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system, Neuroscience, 51, 137, 10.1016/0306-4522(92)90478-K · DOI · Paper page
- Dutta, 2006, Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients, Ann. Neurol., 59, 478, 10.1002/ana.20736 · DOI · Paper page
- El Behi, 2017, Adaptive human immunity drives remyelination in a mouse model of demyelination, Brain, 140, 967, 10.1093/brain/awx008 · DOI · Paper page
- Evangelou, 2013, The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis, Cell Death Differ., 20, 1485, 10.1038/cdd.2013.76 · DOI · Paper page
- Fancy, 2009, Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS, Genes Dev., 23, 1571, 10.1101/gad.1806309 · DOI · Paper page
- Felts, 1992, Conduction properties of central nerve fibers remyelinated by Schwann cells, Brain Res., 574, 178, 10.1016/0006-8993(92)90815-Q · DOI
- Felts, 2005, Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide, Brain, 128, 1649, 10.1093/brain/awh516 · DOI · Paper page
- Foerster, 2019, Diversity in the oligodendrocyte lineage: plasticity or heterogeneity?, Glia, 10.1002/glia.23607 · DOI
- Franklin, 2015, Glia disease and repair—remyelination, Cold Spring Harb. Perspect. Biol., 7, 1, 10.1101/cshperspect.a020594 · DOI · Paper page
- Galloway, 2019, Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination, Glia
- Gilson, 1993, Failure of remyelination in areas of demyelination produced in the spinal cord of old rats, Neuropathol. Appl. Neurobiol., 19, 173, 10.1111/j.1365-2990.1993.tb00424.x · DOI · Paper page
- Goddard, 2001, Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo, Mol. Cell. Neurosci., 18, 557, 10.1006/mcne.2001.1025 · DOI · Paper page
- Haider, 2014, Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron, J. Neurol. Neurosurg. Psychiatry, 85, 1386, 10.1136/jnnp-2014-307712 · DOI · Paper page
- Hamada, 2015, Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability, J. Neurosci., 35, 7272, 10.1523/JNEUROSCI.4747-14.2015 · DOI · Paper page
- Hamanaka, 2018, White-matter repair: interaction between oligodendrocytes and the neurovascular unit, Brain Circ., 4, 118, 10.4103/bc.bc_15_18 · DOI · Paper page
- Hampton, 2012, Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency, Am. J. Pathol., 180, 1897, 10.1016/j.ajpath.2012.01.018 · DOI
- Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- He, 2016, Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination, Nat. Neurosci., 19, 678, 10.1038/nn.4258 · DOI · Paper page
- Hernandez-Segura, 2018, Hallmarks of cellular senescence, Trends Cell Biol., 10.1016/j.tcb.2018.02.001 · DOI · Paper page
- Hoffmann, 2014, Stem cell factor Sox2 and its close relative Sox3 have differentiation functions in oligodendrocytes, Dev., 141, 39, 10.1242/dev.098418 · DOI · Paper page
- Horiuchi, 2012, Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro, Neurobiol. Aging, 33, 499, 10.1016/j.neurobiolaging.2010.05.007 · DOI · Paper page
- Hou, 2017, Ginsenoside Rg3 prevents oxidative stress-induced astrocytic senescence and ameliorates senescence paracrine effects on glioblastoma, Molecules, 22, 10.3390/molecules22091516 · DOI · Paper page
- Hou, 2018, Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype, Chem. Biol. Interact., 283, 75, 10.1016/j.cbi.2018.02.002 · DOI
- Itoyama, 1983, Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions, Ann. Neurol., 14, 339, 10.1002/ana.410140313 · DOI · Paper page
- Jarjour, 2003, Netrin-1 is a chemorepellent for oligodendrocyte precursor cells in the embryonic spinal cord, J. Neurosci., 23, 3735, 10.1523/JNEUROSCI.23-09-03735.2003 · DOI · Paper page
- Jeffries, 2016, ERK1/2 activation in preexisting oligodendrocytes of adult mice drives new myelin synthesis and enhanced CNS function, J. Neurosci., 36, 9186, 10.1523/JNEUROSCI.1444-16.2016 · DOI · Paper page
- John, 2002, Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation, Nat. Med., 8, 1115, 10.1038/nm781 · DOI · Paper page
- Kernt, 2013, Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio, J Glaucoma, 22, 404, 10.1097/IJG.0b013e31824caf90 · DOI
- Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol., 157, 267, 10.1016/S0002-9440(10)64537-3 · DOI · Paper page
- Koutsoudaki, 2010, Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV, Neuroscience, 171, 235, 10.1016/j.neuroscience.2010.08.070 · DOI · Paper page
- Kremer, 2019, Current advancements in promoting remyelination in multiple sclerosis, Mult. Scler. J., 10.1177/1352458518800827 · DOI
- Krenning, 2014, Transient activation of p53 in G2 phase is sufficient to induce senescence, Mol. Cell, 55, 59, 10.1016/j.molcel.2014.05.007 · DOI · Paper page
- Kuhlmann, 2008, Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis, Brain, 131, 1749, 10.1093/brain/awn096 · DOI · Paper page
- Lalive, 2005, TGF-β-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway, Eur. J. Immunol., 35, 727, 10.1002/eji.200425430 · DOI · Paper page
- Lassmann, 2016, Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions, Biochim. Biophys. Acta Mol. Basis Dis, 1862, 506, 10.1016/j.bbadis.2015.09.018 · DOI · Paper page
- Lentferink, 2018, Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination, Sci. Rep., 8, 10.1038/s41598-018-19934-6 · DOI
- Leray, 2010, Evidence for a two-stage disability progression in multiple sclerosis, Brain, 133, 1900, 10.1093/brain/awq076 · DOI · Paper page
- Liebetanz, 2006, Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis, Exp. Neurol., 202, 217, 10.1016/j.expneurol.2006.05.032 · DOI · Paper page
- Lin, 2012, Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells, Mol. Biol. Cell, 23, 1569, 10.1091/mbc.e11-10-0849 · DOI · Paper page
- Lloyd, 2016, Cellular and molecular mechanisms underpinning macrophage activation during remyelination, Front. Cell Dev. Biol., 10.3389/fcell.2016.00060 · DOI · Paper page
- Lovas, 2000, Axonal changes in chronic demyelinated cervical spinal cord plaques, Brain, 123, 308, 10.1093/brain/123.2.308 · DOI · Paper page
- Ludwin, 1984, Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths, J. Neurol. Sci., 64, 193, 10.1016/0022-510X(84)90037-6 · DOI
- Marqués-Torrejón, 2013, Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression, Cell Stem Cell, 12, 88, 10.1016/j.stem.2012.12.001 · DOI · Paper page
- Martínez-Cué, 2020, Cellular senescence in neurodegenerative diseases, Front. Cell. Neurosci., 14, 10.3389/fncel.2020.00016 · DOI · Paper page
- McKay, 2015, Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review, Biomed Res. Int., 10.1155/2015/817238 · DOI
- McKinnon, 1990, FGF modulates the PDGF-driven pathway of oligodendrocyte development, Neuron, 5, 603, 10.1016/0896-6273(90)90215-2 · DOI · Paper page
- Mecha, 2013, Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler’s virus model of multiple sclerosis: implications for remyelination at lesions sites, Exp. Neurol., 250, 348, 10.1016/j.expneurol.2013.10.011 · DOI
- Mei, 2016, Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery, Elife, 5, 10.7554/eLife.18246 · DOI · Paper page
- Mi, 2005, LINGO-1 negatively regulates myelination by oligodendrocytes, Nat. Neurosci., 8, 745, 10.1038/nn1460 · DOI · Paper page
- Milner, 1997, Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration, Glia, 19, 85, 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9 · DOI · Paper page
- Miron, 2011, Cells of the oligodendroglial lineage, myelination, and remyelination, Biochim. Biophys. Acta Mol. Basis Dis., 10.1016/j.bbadis.2010.09.010 · DOI · Paper page
- Mitew, 2018, Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner, Nat. Commun., 9, 10.1038/s41467-017-02719-2 · DOI · Paper page
- Mitrovič, 2018, Low- frequency and rare-coding variation contributes to multiple sclerosis risk, Cell, 175, 1679, 10.1016/j.cell.2018.09.049 · DOI · Paper page
- Montalban, 2018, Cladribine tablets added to IFN-β in active relapsing MS, Neurol. Neuroimmunol. NeuroInflammation, 5, 10.1212/NXI.0000000000000477 · DOI
- Morgan-Hughes, 1968, Experimental diphtheritic neuropathy. A pathological and electrophysiological study, J. Neurol. Sci., 7, 157, 10.1016/0022-510X(68)90011-7 · DOI
- Muñoz- Espín, 2014, Cellular senescence: from physiology to pathology, Nat. Rev. Mol. Cell Biol., 10.1038/nrm3823 · DOI · Paper page
- Mutsaers, 1998, Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve, Acta Neuropathol., 96, 139, 10.1007/s004010050873 · DOI
- Nakamura, 2008, Both telomeric and non- telomeric DNA damage are determinants of mammalian cellular senescence, Epigenetics Chromatin, 1, 10.1186/1756-8935-1-6 · DOI · Paper page
- Neumann, 2019, Metformin restores CNS remyelination capacity by rejuvenating aged stem cells, Cell Stem Cell, 25, 473, 10.1016/j.stem.2019.08.015 · DOI · Paper page
- Nicaise, 2019, Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis, Proc. Natl. Acad. Sci. U. S. A., 116, 9030, 10.1073/pnas.1818348116 · DOI · Paper page
- Noble, 2003, The cortical ancestry of oligodendrocytes: common principles and novel features, Dev. Neurosci., 10.1159/000072270 · DOI
- Oost, 2018, Targeting senescence to delay progression of multiple sclerosis, J. Mol. Med., 10.1007/s00109-018-1686-x · DOI
- Ortiz, 2019, Neuronal activity in vivo enhances functional myelin repair, JCI Insight, 4, 10.1172/jci.insight.123434 · DOI · Paper page
- Papadopoulos, 2006, Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat, Exp. Neurol., 197, 373, 10.1016/j.expneurol.2005.10.033 · DOI · Paper page
- Papageorgis, 2017, Complex interplay between aging and cancer: role of TGF-β signaling, Crit. Rev. Oncog., 10.1615/CritRevOncog.2017025134 · DOI
- Pardo, 2017, The sequence of disease- modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations, J. Neurol.
- Patani, 2007, Remyelination can be extensive in multiple sclerosis despite a long disease course, Neuropathol Appl Neurobiol, 33, 277, 10.1111/j.1365-2990.2007.00805.x · DOI · Paper page
- Patrikios, 2006, Remyelination is extensive in a subset of multiple sclerosis patients, Brain, 129, 3165, 10.1093/brain/awl217 · DOI · Paper page
- Petersen, 2017, Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage, Neuron, 96, 1003, 10.1016/j.neuron.2017.10.008 · DOI · Paper page
- Poliak, 2003, The local differentiation of myelinated axons at nodes of ranvier, Nat. Rev. Neurosci., 10.1038/nrn1253 · DOI · Paper page
- Prozorovski, 2019, Regulation of sirtuin expression in autoimmune neuroinflammation: induction of SIRT1 in oligodendrocyte progenitor cells, Neurosci. Lett., 704, 116, 10.1016/j.neulet.2019.04.007 · DOI
- Raine, 2017, Multiple sclerosis: the resolving lesion revealed, J. Neuroimmunol., 304, 2, 10.1016/j.jneuroim.2016.05.021 · DOI
- Ren, 2009, Inflammatory signaling and cellular senescence, Cell. Signal., 10.1016/j.cellsig.2008.10.011 · DOI · Paper page
- Rivera, 2019, Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination, Glia, 67, 1510, 10.1002/glia.23624 · DOI
- Sabin, 2011, Cellular Senescence - its role in cancer and the response to ionizing radiation, Genome Integr., 10.1186/2041-9414-2-7 · DOI · Paper page
- Saida, 1980, Antiserum‐mediated demyelination: relationship between remyelination and functional recovery, Ann. Neurol., 8, 12, 10.1002/ana.410080103 · DOI
- Scott-Hewitt, 2017, Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury, Hum. Mol. Genet., 26, 2825, 10.1093/hmg/ddx153 · DOI
- Sedal, 1983, A combined morphological and electrophysiological study of conduction block in peripheral nerve, J. Neurol. Sci., 60, 293, 10.1016/0022-510X(83)90070-9 · doi:10.1016/0022-510x(83)90070-9
- Shen, 2008, Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency, Nat. Neurosci., 11, 1024, 10.1038/nn.2172 · DOI · Paper page
- Shields, 1999, Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination, Glia, 28, 77, 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F · DOI · Paper page
- Shrager, 1988, Ionic channels and signal conduction in single remyelinating frog nerve fibres, J. Physiol., 404, 695, 10.1113/jphysiol.1988.sp017314 · doi:10.1113/jphysiol.1988.sp017314
- Sim, 2002, The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation, J. Neurosci., 22, 2451, 10.1523/JNEUROSCI.22-07-02451.2002 · DOI · Paper page
- Smith, 1980, Nerve conduction during peripheral demyelination and remyelination, Top. Catal., 48, 201
- Smith, 1979, Central remyelination restores secure conduction [12], Nature
- Smith, 1981, The restoration of conduction by central remyelination, Brain, 104, 647, 10.1093/brain/104.2.383 · DOI · Paper page
- Stancic, 2012, Galectin-4, a novel neuronal regulator of myelination, Glia, 60, 919, 10.1002/glia.22324 · DOI · Paper page
- Tepavčević, 2014, Early netrin-1 expression impairs central nervous system remyelination, Ann. Neurol., 76, 252, 10.1002/ana.24201 · DOI · Paper page
- Thümmler, 2019, Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential, Acta Neuropathol. Commun., 7, 10.1186/s40478-019-0864-6 · DOI
- Tian, 2018, CXCL12 induces migration of oligodendrocyte precursor cells through the CXCR4‑activated MEK/ERK and PI3K/AKT pathways, Mol. Med. Rep., 18, 4374
- Tobin, 2011, Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging, J. Neuropathol. Exp. Neurol., 70, 157, 10.1097/NEN.0b013e31820937e4 · DOI · Paper page
- Verden, 2016, Neuroprotection by central nervous system remyelination: molecular, cellular, and functional considerations, J. Neurosci. Res., 10.1002/jnr.23923 · DOI
- Wang, 1998, Notch receptor activation inhibits oligodendrocyte differentiation, Neuron, 21, 10.1016/S0896-6273(00)80515-2 · DOI · Paper page
- Williams, 2007, Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?, Brain, 130, 2554, 10.1093/brain/awm202 · DOI · Paper page
- Xia, 2020, Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease, J. Neuroinflammation, 17, 105, 10.1186/s12974-020-01791-8 · DOI · Paper page
- Yabluchanskiy, 2020, Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation–induced impairment of neurovascular coupling responses protecting cognitive function in mice, GeroScience, 10.1007/s11357-020-00154-8 · DOI
- Yamada, 1998, White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues, Exp. Neurol., 153, 60, 10.1006/exnr.1998.6874 · DOI
- Yin, 2014, Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish, Exp. Neurol., 251, 72, 10.1016/j.expneurol.2013.11.012 · DOI
- Zambonin, 2011, Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis, Brain, 134, 1901, 10.1093/brain/awr110 · DOI · Paper page
- Zawadzka, 2010, CNS-resident glial Progenitor/Stem cells produce schwann cells as well as oligodendrocytes during repair of CNS demyelination, Cell Stem Cell, 6, 578, 10.1016/j.stem.2010.04.002 · DOI · Paper page
- Zhang, 2010, TGFβ1 induces Jagged1 expression in astrocytes via ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor proliferation and differentiation, Glia, 58, 964, 10.1002/glia.20978 · DOI · Paper page
- Zhang, 2018, Sox2 is essential for oligodendroglial proliferation and differentiation during postnatal brain myelination and CNS remyelination, J. Neurosci., 38, 1802, 10.1523/JNEUROSCI.1291-17.2018 · DOI · Paper page
- Zhou, 2019, Age-related changes in the global DNA methylation profile of oligodendrocyte progenitor cells derived from rat spinal cords, Curr. Med. Sci., 39, 67, 10.1007/s11596-019-2001-y · DOI
- Zhu, 2014, Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging, PLoS One, 9
Cited by
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
García-Domínguez, M. (2025) · Cells · doi:10.3390/cells14181408 · Cited by 13
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
Microglial states associate with lesion dynamics in multiple sclerosis
van den Bosch, A. M. R., Khoo, J. H., Lu, Z., Liang, H., Wever, D., Pu, L., Eggen, B. J. L., Uhlén, M., Smolders, J., Hamann, J., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117538 · Cited by 13
Metadata
- Authors
- Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G.
- Venue
- Mechanisms of Ageing and Development
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 192
- Pages
- 111366
- ISSN
- 0047-6374 (ISSN-L)
- OpenAlex
- W3091536782
- Cited by
- 33
- References
- 88
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Hellenic Foundation for Research and Innovation
- H2020 Marie Skłodowska-Curie Actions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cellular senescence and failure of myelin repair in multiple sclerosis. https://app.cochat.ai/papers/10.1016/j.mad.2020.111366
- The paper
- Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020). Cellular senescence and failure of myelin repair in multiple sclerosis. Mechanisms of Ageing and Development. https://doi.org/10.1016/j.mad.2020.111366
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.